De Belder Jonas, Matthysen Stijn, Claes Annes J, Mertens Griet, Van de Heyning Paul, Van Rompaey Vincent
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium.
Front Neurosci. 2018 Jan 9;11:735. doi: 10.3389/fnins.2017.00735. eCollection 2017.
Cognitive impairment has been observed in patients with bilateral vestibular loss (BVL) and in patients with sensorineural hearing loss (SNHL). DFNA9 is an autosomal dominant disorder that causes a combination of both sensory deficits by the 3rd to 5th decade. We therefore hypothesize a combined detrimental effect on cognition. The aim of this systematic review was to identify studies related to DFNA9 in general and its relationship with cognitive impairment more specifically. Several databases including Medline, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, ISI Web of Knowledge, and Web of Science were searched to accumulate information about DFNA9-mutations, including phenotype, genotype, pathophysiology, quality of life (QOL), and imaging in general and cognitive function more specifically. A qualitative analysis was performed on the 55 articles that qualified. The clinical features of DFNA9 are different along the 24 COCH mutations, described up to now. Vestibular symptoms generally present themselves a few years after SNHL onset in mutations associated with the vWFA-domain although they can precede SNHL onset in other mutations associated with the LCCL-domain. QoL has not been studied extensively in DFNA9, although scarce work is available on the positive impact of cochlear implantation to rehabilitate hearing. No studies were found evaluating cognition in DFNA9 patients. Although cognitive impairment has been demonstrated in patients with hearing loss as well as in patients with BVL, no studies have been reported on the combination of both sensory deficits, such as in DFNA9. Further research is warranted to correlate otovestibular status with cognition.
在双侧前庭丧失(BVL)患者和感音神经性听力损失(SNHL)患者中均观察到认知障碍。DFNA9是一种常染色体显性疾病,会在30至50岁时导致两种感觉缺陷同时出现。因此,我们推测其对认知具有联合有害作用。本系统评价的目的是确定与DFNA9总体相关的研究,更具体地说是其与认知障碍的关系。检索了多个数据库,包括医学文献数据库(Medline)、Cochrane系统评价数据库、Cochrane对照试验中心注册库、科学引文索引(ISI)数据库和科学网(Web of Science),以收集有关DFNA9突变的信息,包括一般的表型、基因型、病理生理学、生活质量(QOL)和影像学,更具体地说是认知功能。对符合条件的55篇文章进行了定性分析。截至目前所描述的24种COCH突变,DFNA9的临床特征各不相同。在前庭膜蛋白A结构域(vWFA)相关突变中,前庭症状通常在SNHL发病后数年出现,而在富含半胱氨酸的C型凝集素样结构域(LCCL)相关的其他突变中,前庭症状可能在SNHL发病之前出现。DFNA9患者的生活质量尚未得到广泛研究,尽管关于人工耳蜗植入对听力康复的积极影响有少量研究。未发现评估DFNA9患者认知的研究。虽然听力损失患者和BVL患者均已证实存在认知障碍,但尚无关于两种感觉缺陷合并存在情况(如DFNA9)的研究报道。有必要进一步开展研究,以关联耳前庭状态与认知。